NEW YORK, April 2 – Luminex of Austin, Texas, said Monday it had licensed two components of Tm Bioscience’s microarray technology for use in its LabMAP, bead-based genomic analysis system.

Toronto-based Tm has also signed a multi-year partnership with Luminex, granting Tm rights to develop and market diagnostic products based on Luminex's LabMAP technology. LabMap uses microspheres, small lasers, digital processors, and software to perform up to 100 assays per drop of fluid.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.